Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Askling

Showing results (11-20 of 345) with videos related to

Pageof 35
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|July 1, 2017
Editorial: Is Rheumatoid Arthritis a Mortal Disease?Johan Askling, Marie Holmqvist, Lotta Ljung
Annals of the Rheumatic Diseases|October 4, 2017
Mortality following new-onset Rheumatoid Arthritis: has modern Rheumatology had an impact?Marie Holmqvist, Lotta Ljung, Johan Askling
The British Journal of Dermatology|February 25, 2025
Incidence, stage and outcome of melanoma, keratinocyte and other cancers in individuals with vitiligo or alopecia: intraindividual or familial risks?Benedicte Delcoigne, Josefin Lysell, Johan Askling
RMD Open|November 16, 2023
Register-based observational study of associations between inflammatory remission, formal treatment targets and the use of disease-modifying antirheumatic drugs among patients with early rheumatoid arthritisJoakim Lindqvist, Johan Askling, Jon Lampa
RMD Open|May 20, 2020
Siblings of patients with rheumatoid arthritis have an increased mortality rate: a Swedish cohort studyHelga Westerlind, Bénédicte Delcoigne, Johan Askling
Arthritis and Rheumatism|January 1, 2008
Risks and relative risks of Wegener's granulomatosis among close relatives of patients with the diseaseAnn Knight, Sven Sandin, Johan Askling
The Journal of Rheumatology|October 5, 2010
Increased risk of autoimmune disease in families with Wegener's granulomatosisAnn Knight, Sven Sandin, Johan Askling
International Journal of Cancer|July 13, 2002
Cancer incidence in a population-based cohort of patients with Wegener's granulomatosisAnn Knight, Johan Askling, Anders Ekbom
Annals of the Rheumatic Diseases|April 15, 2009
Occupational risk factors for Wegener's granulomatosis: a case-control studyAnn Knight, Sven Sandin, Johan Askling
Annals of the Rheumatic Diseases|August 10, 2014
TNF inhibitor therapy and risk of breast cancer recurrence in patients with rheumatoid arthritis: a nationwide cohort studyPauline Raaschou, Thomas Frisell, Johan Askling, et al.
Pageof 35

Showing results (11-20 of 345) with videos related to

Sort By:
Pageof 35
Arthritis & Rheumatology (Hoboken, N.J.)|July 1, 2017
Editorial: Is Rheumatoid Arthritis a Mortal Disease?Johan Askling, Marie Holmqvist, Lotta Ljung
Annals of the Rheumatic Diseases|October 4, 2017
Mortality following new-onset Rheumatoid Arthritis: has modern Rheumatology had an impact?Marie Holmqvist, Lotta Ljung, Johan Askling
The British Journal of Dermatology|February 25, 2025
Incidence, stage and outcome of melanoma, keratinocyte and other cancers in individuals with vitiligo or alopecia: intraindividual or familial risks?Benedicte Delcoigne, Josefin Lysell, Johan Askling
RMD Open|November 16, 2023
Register-based observational study of associations between inflammatory remission, formal treatment targets and the use of disease-modifying antirheumatic drugs among patients with early rheumatoid arthritisJoakim Lindqvist, Johan Askling, Jon Lampa
RMD Open|May 20, 2020
Siblings of patients with rheumatoid arthritis have an increased mortality rate: a Swedish cohort studyHelga Westerlind, Bénédicte Delcoigne, Johan Askling
Arthritis and Rheumatism|January 1, 2008
Risks and relative risks of Wegener's granulomatosis among close relatives of patients with the diseaseAnn Knight, Sven Sandin, Johan Askling
The Journal of Rheumatology|October 5, 2010
Increased risk of autoimmune disease in families with Wegener's granulomatosisAnn Knight, Sven Sandin, Johan Askling
International Journal of Cancer|July 13, 2002
Cancer incidence in a population-based cohort of patients with Wegener's granulomatosisAnn Knight, Johan Askling, Anders Ekbom
Annals of the Rheumatic Diseases|April 15, 2009
Occupational risk factors for Wegener's granulomatosis: a case-control studyAnn Knight, Sven Sandin, Johan Askling
Annals of the Rheumatic Diseases|August 10, 2014
TNF inhibitor therapy and risk of breast cancer recurrence in patients with rheumatoid arthritis: a nationwide cohort studyPauline Raaschou, Thomas Frisell, Johan Askling, et al.
Pageof 35